Black Rock Inc. Cns Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.43 $10,682 - $17,667	-41,087 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.26 - $1.05 $186 - $751	-716 Reduced 1.71%	41,087 $14,000
Q4 2021 Feb 10, 2022	BUY	$0.7 - $1.54 $759 - $1,670	1,085 Added 2.66%	41,803 $29,000
Q3 2021 Nov 09, 2021	SELL	$1.4 - $1.98 $1,215 - $1,718	-868 Reduced 2.09%	40,718 $60,000
Q2 2021 Aug 11, 2021	BUY	$1.71 - $2.42 $71,112 - $100,638	41,586 New	41,586 $82,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $5.2M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.